Respiratory syncytial virus vaccine (Immunovaccine)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameRespiratory syncytial virus vaccine (Immunovaccine)
Drug Alias NameDPX-RSV VaccineDPXRSV (A)DepoVaxDPX-RSV
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionVirus replication inhibitorsImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesImmunovaccine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDalhousie University
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A